Petasites extract Ze 339 (PET) inhibits allergen-induced Th2 responses, airway inflammation and airway hyperreactivity in mice

Phytotherapy Research

Volumn 24, Issue 5, 2010, Pages 680-685

  Brattstrom A ^a   Schapowal, A ^b   Maillet, I ^c   Schnyder, B ^c   Ryffel, B ^c   Moser, René ^d,e  

^a Max Zeller Sohne AG   (Switzerland)

^b Dr Schapowal Praxis ^*  (Switzerland)

^c UNIVERSITÉ D'ORLÉANS   (France)

^d IBR Inc   (Switzerland)

^e Biomedical Research Foundation   (Switzerland)

Author keywords

Airway hyperreactivity; Allergic airway inflammation; Immune response reduction; Leukotriene synthesis inhibitor; Murine asthma model; Petasites extract PET

Indexed keywords

ALLERGEN; ANTIALLERGIC AGENT; EOSINOPHIL PEROXIDASE; EOTAXIN; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; PETASITES HYBRIDUS EXTRACT; RANTES; UNCLASSIFIED DRUG; ZE 339;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; EOSINOPHIL; IMMUNOGLOBULIN BLOOD LEVEL; LUNG LAVAGE; MOUSE; MUCUS SECRETION; NONHUMAN; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; TH2 CELL;

ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINE CCL5; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; EOSINOPHIL PEROXIDASE; EOSINOPHILS; IMMUNOGLOBULIN E; INTERLEUKIN-4; INTERLEUKIN-5; MICE; MICE, INBRED BALB C; MUCUS; OVALBUMIN; PETASITES; PHYTOTHERAPY; PLANT EXTRACTS; TH2 CELLS;

MURINAE; MUS; PETASITES; PETASITES HYBRIDUS;

EID: 77952082511     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2972     Document Type: Article

References (32)

1. Ahern DJ, Robinson DS. 2005. Regulatory T cells as a target for induction of immune tolerance in allergy. Curr Opin Allergy Clin Immunol 5: 531-536. (Pubitemid 41679989)
2. Andersson CK, Claesson HE, Rydell-Tormanen K, Swedmark S, Hallgren A, Erjefalt JS. 2008. Mice lacking 12/15- lipoxygenase have attenuated airway allergic inflammation and remodeling. Am J Respir Cell Mol Biol 39: 648-656.
3. Barnes PJ. 2008. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 8: 183-192. (Pubitemid 351323287)
4. Cao RY, St Amand T, Grabner R, Habenicht AJ, Funk CD. 2008. Genetic and pharmacological inhibition of the 5-lipoxygenase/leukotriene pathway in atherosclerotic lesion development in ApoE defi cient mice. Atherosclerosis 203: 395-400.
5. Cheraim AB, Xavier-Elsas P, de Oliveira SH et al. 2008. Leukotriene B4 is essential for selective eosinophil recruitment following allergen challenge of CD4+ cells in a model of chronic eosinophilic infl ammation. Life Sci 83: 214-222.
6. Couillin I, Maillet I, Vargaftig BB et al. 2004. Arthropod-derived histamine-binding protein prevents murine allergic asthma. J Immunol 173: 3281-3286.
7. Fiebich BL, Grozdeva M, Hess S et al. 2005. Petasites hybridus extracts in vitro inhibit COX-2 and PGE2 release by direct interaction with the enzyme and by preventing p42/44 MAP kinase activation in rat primary microglial cells. Planta Med 71: 12-19.
8. Henderson WRJ, Tang LO, Chu SJ et al. 2002. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med 165: 108-116.
9. Hicks A, Monkarsh SP, Hoffman AF, Goodnow RJ. 2007. Leukotriene B4 receptor antagonists as therapeutics for infl ammatory disease: preclinical and clinical developments. Expert Opin Investig Drugs 16: 1909-1920.
10. Holgate ST, Polosa R. 2008. Treatment strategies for allergy and asthma. Nat Rev Immunol 8: 218-230.
11. Kips JC, Anderson GP, Fredberg JJ et al. 2003. Murine models of asthma. Eur Respir J 22: 374-382.
12. Moser R, Fehr J, Bruijnzeel PL. 1992a. IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. J Immunol 149: 1432-1438.
13. Moser R, Fehr J, Olgiati L, Bruijnzeel PL. 1992b. Migration of primed human eosinophils across cytokine-activated endothelial cell monolayers. Blood 79: 2937-2945.
14. Ohkawara Y, Lei XF, Stampfli MR, Marshall JS, Xing Z, Jordana M. 1997. Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation. Am J Respir Cell Mol Biol 16: 510-520.
15. Ohnishi H, Miyahara N, Gelfand EW. 2008. The role of leukotriene b(4) in allergic diseases. Allergol Int 57: 291-298.
16. Qiu H, Johansson AS, Sjostrom M et al. 2006. Differential induction of BLT receptor expression on human endothelial cells by lipopolysaccharide, cytokines, and leukotriene B4. Proc Natl Acad Sci USA 103: 6913-6918.
17. Robinson DS. 2000. Th-2 cytokines in allergic disease. Br Med Bull 56: 956-968.
18. Schapowal A. 2002. Randomised controlled trial of butterbur and cetirizine for treating seasonal allergic rhinitis. Br Med J 324: 144-146.
19. Schapowal A. 2004. Butterbur Ze339 for the treatment of intermittent allergic rhinitis: dose-dependent effi cacy in a prospective, randomized, double-blind, placebo-controlled study. Arch Otolaryngol Head Neck Surg 130: 1381-1386.
20. Schapowal A. 2005. Treating intermittent allergic rhinitis: a prospective, randomized, placebo and antihistaminecontrolled study of Butterbur extract Ze 339. Phytother Res 19: 530-537.
21. Shimoda H, Tanaka J, Yamada E, Morikawa T, Kasajima N, Yoshikawa M. 2006. Anti type I allergic property of Japanese butterbur extract and its mast cell degranulation inhibitory ingredients. J Agric Food Chem 54: 2915-2920.
22. Simon D, Simon HU. 2007. Eosinophilic disorders. J Allergy Clin Immunol 119: 1291-1300; quiz 1301-11292
23. Spahr JE, Krawiec ME. 2004. Leukotriene receptor antagonists-risks and benefi ts for use in paediatric asthma. Expert Opin Drug Saf 3: 173-185.
24. Thomet OA, Schapowal A, Heinisch IV, Wiesmann UN, Simon HU. 2002. Anti-infl ammatory activity of an extract of Petasites hybridus in allergic rhinitis. Int Immunopharmacol 2: 997-1006.
25. Thomet OA, Wiesmann UN, Blaser K, Simon HU. 2001a. Differential inhibition of infl ammatory effector functions by petasin, isopetasin and neopetasin in human eosinophils. Clin Exp Allergy 31: 1310-1320.
26. Thomet OA, Wiesmann UN, Schapowal A, Bizer C, Simon HU. 2001b. Role of petasin in the potential anti-inflammatory activity of a plant extract of Petasites hybridus. Biochem Pharmacol 61: 1041-1047.
27. Wang Y, McCusker CT. 2005. Interleukin-13-dependent bronchial hyper-responsiveness following isolated upper-airway allergen challenge in a murine model of allergic rhinitis and asthma. Clin Exp Allergy 35: 1104-1111.
28. Wegmann M, Fehrenbach H, Fehrenbach A et al. 2005. Involvement of distal airways in a chronic model of experimental asthma. Clin Exp Allergy 35: 1263-1271.
29. Wills-Karp M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 17: 255-281.
30. Yamaoka KA, Dugas B, Paul-Eugene N, Mencia-Huerta JM, Braquet P, Kolb JP. 1994. Leukotriene B4 enhances IL-4-induced IgE production from normal human lymphocytes. Cell Immunol 156: 124-134.
31. Yokomizo T, Izumi T, Chang K, Takuwa Y, Shimizu T. 1997. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 387: 620-624.
32. Yokomizo T, Kato K, Terawaki K, Izumi T, Shimizu T. 2000. A second leukotriene B(4) receptor, BLT2. A new therapeutic target in infl ammation and immunological disorders. J Exp Med 192: 421-432.